These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32451257)

  • 41. Coronavirus disease 2019: A new severe acute respiratory syndrome from Wuhan in China.
    Cao Y; Cai K; Xiong L
    Acta Virol; 2020; 64(2):245-250. PubMed ID: 32551792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Wuhan SARS-CoV-2-What's next for China.
    Lu H; Stratton CW; Tang YW
    J Med Virol; 2020 Jun; 92(6):546-547. PubMed ID: 32115732
    [No Abstract]   [Full Text] [Related]  

  • 43. COVID-19 Infection Fatality Rates: The Author Replies.
    Basu A
    Health Aff (Millwood); 2020 Aug; 39(8):1462-1463. PubMed ID: 32744937
    [No Abstract]   [Full Text] [Related]  

  • 44. Estimating case fatality rates of COVID-19.
    Kim DD; Goel A
    Lancet Infect Dis; 2020 Jul; 20(7):773-774. PubMed ID: 32243814
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.
    Ruan Q; Yang K; Wang W; Jiang L; Song J
    Intensive Care Med; 2020 May; 46(5):846-848. PubMed ID: 32125452
    [No Abstract]   [Full Text] [Related]  

  • 46. COVID-19 fatality rate for Saudi Arabia, updated 3 June 2020.
    Boretti A
    J Glob Antimicrob Resist; 2020 Sep; 22():845-846. PubMed ID: 32745636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In times of COVID-19, epidemiology is a unifying science.
    Souza CDF
    Rev Assoc Med Bras (1992); 2020; 66Suppl 2(Suppl 2):27-30. PubMed ID: 32965351
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Understanding and Interpretation of Case Fatality Rate of Coronavirus Disease 2019.
    Kim DH; Choe YJ; Jeong JY
    J Korean Med Sci; 2020 Mar; 35(12):e137. PubMed ID: 32233163
    [No Abstract]   [Full Text] [Related]  

  • 49. Massive migration promotes the early spread of COVID-19 in China: a study based on a scale-free network.
    Song WY; Zang P; Ding ZX; Fang XY; Zhu LG; Zhu Y; Bao CJ; Chen F; Wu M; Peng ZH
    Infect Dis Poverty; 2020 Aug; 9(1):109. PubMed ID: 32778160
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How Do Colleges and Universities Respond to Covid-19: The Experience of Chengdu Sport University.
    Kan M; Zhou J
    Asia Pac J Public Health; 2020 May; 32(4):170-171. PubMed ID: 32580564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Infection Rate of COVID-19 in Wuhan, China: Combined Analysis of Population Samples.
    Qu HQ; Cheng ZJ; Duan Z; Tian L; Hakonarson H
    J Med Internet Res; 2020 Aug; 22(8):e20914. PubMed ID: 32707538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spatiotemporal evolution of case fatality rates of COVID-19 in Brazil, 2020.
    Souza CDF; Paiva JPS; Leal TC; Silva LFD; Santos LG
    J Bras Pneumol; 2020 Jun; 46(4):e20200208. PubMed ID: 32578681
    [No Abstract]   [Full Text] [Related]  

  • 53. The many estimates of the COVID-19 case fatality rate.
    Rajgor DD; Lee MH; Archuleta S; Bagdasarian N; Quek SC
    Lancet Infect Dis; 2020 Jul; 20(7):776-777. PubMed ID: 32224313
    [No Abstract]   [Full Text] [Related]  

  • 54. New Measures for the Coronavirus Disease 2019 Response: A Lesson From the Wenzhou Experience.
    Ruan L; Wen M; Zeng Q; Chen C; Huang S; Yang S; Yang J; Wang J; Hu Y; Ding S; Zhang Y; Zhang H; Feng Y; Jin K; Zhuge Q
    Clin Infect Dis; 2020 Jul; 71(15):866-869. PubMed ID: 32246149
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estimates of the severity of coronavirus disease 2019: a model-based analysis.
    Verity R; Okell LC; Dorigatti I; Winskill P; Whittaker C; Imai N; Cuomo-Dannenburg G; Thompson H; Walker PGT; Fu H; Dighe A; Griffin JT; Baguelin M; Bhatia S; Boonyasiri A; Cori A; Cucunubá Z; FitzJohn R; Gaythorpe K; Green W; Hamlet A; Hinsley W; Laydon D; Nedjati-Gilani G; Riley S; van Elsland S; Volz E; Wang H; Wang Y; Xi X; Donnelly CA; Ghani AC; Ferguson NM
    Lancet Infect Dis; 2020 Jun; 20(6):669-677. PubMed ID: 32240634
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Surgical treatment strategy for digestive system malignancies during the outbreak of COVID-19].
    Ma FH; Hu HT; Tian YT
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):180-183. PubMed ID: 32096396
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Real-time estimation and prediction of mortality caused by COVID-19 with patient information based algorithm.
    Wang L; Li J; Guo S; Xie N; Yao L; Cao Y; Day SW; Howard SC; Graff JC; Gu T; Ji J; Gu W; Sun D
    Sci Total Environ; 2020 Jul; 727():138394. PubMed ID: 32334207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High altitude reduces infection rate of COVID-19 but not case-fatality rate.
    Segovia-Juarez J; Castagnetto JM; Gonzales GF
    Respir Physiol Neurobiol; 2020 Oct; 281():103494. PubMed ID: 32679369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status.
    Lai CC; Wang CY; Wang YH; Hsueh SC; Ko WC; Hsueh PR
    Int J Antimicrob Agents; 2020 Apr; 55(4):105946. PubMed ID: 32199877
    [TBL] [Abstract][Full Text] [Related]  

  • 60. First, second and potential third generation spreads of the COVID-19 epidemic in mainland China: an early exploratory study incorporating location-based service data of mobile devices.
    Hu B; Qiu J; Chen H; Tao V; Wang J; Lin H
    Int J Infect Dis; 2020 Jul; 96():489-495. PubMed ID: 32425632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.